CDK4/6 inhibitors

Open Access
Management of Severe Abemaciclib-induced Liver Dysfunction: Feasibility of Switching to Palbociclib
SHINYA TAKADA, KENGO UMEHARA and KENICHI WATANABE

In Vivo January 2026, 40 (1) 532-537; DOI: https://doi.org/10.21873/invivo.14217
Open Access
An Overview of the Roles of CDK4/6 Inhibitors in Metastatic Breast Cancer Elderly Patients
CARMEN PACILIO, GERARDO ROSATI, ANNA CRISPO, SABRINA BIMONTE, FRANCESCA DI RELLA, FRANCESCO NUZZO and MICHELINO DE LAURENTIIS

In Vivo July 2023, 37 (4) 1445-1449; DOI: https://doi.org/10.21873/invivo.13228

Main menu